2025-01-13XThread

Source item

.@SurbhiSarnaSF is an unstoppable force. I asked if we could invest one sentence into our convo about her starting another company. Incredibly excited to see Collate (and the mission-driven applied AI team led by her + @nateps) accelerate the pace of innovation in biotech. more from @alexrkonrad: https://t.co/SnEppEDKGe

2 segments

Segment 1 · characters 0–274 · Original segment ↗

Segment 2 · characters 276–323 · Original segment ↗

Quoted context

These are the quoted author’s words.

Exclusive: Y Combinator partner Surbhi Sarna has raised $30 million for a new startup, Collate, looking to bring AI to tedious paperwork for life sciences companies. @amyfeldman and I spoke to Sarna, who previously sold nVision Medical, for @forbes. https://t.co/FVdE8OxpHs
alexrkonrad ↗

I’m excited to introduce Collate and announce our $30M seed round. We’re using AI to help solve one of the biggest problems for life sciences companies — the never-ending cycle of document creation and maintenance you need to do to stay compliant. While running my first company, I experienced the burden of documentation that life science companies face – from R&D to commercial readiness. Then at YC, I was lucky enough to witness the transformative, inevitable nature of software and AI. There's a unique opportunity here to bridge my two worlds. I'm thrilled to be building this alongside @nateps and @jigishjpatel. Thank you to our investors who have backed us with a $30M seed round: Satish Dharmaraj at Redpoint, @joshk at First Round and @saranormous at Conviction. And of course, YC. To YC and @garrytan - thank you for the invaluable gifts: a family of GPs I'll always count on, a deeper appreciation for software's potential, and most preciously, the privilege of supporting so many remarkable founders on their journeys. https://t.co/su1uxlVITn
SurbhiSarnaSF ↗